No small matter: MicroRNAs - key regulators of cancer stem cells

International Journal of Clinical and Experimental Medicine

Volumn 3, Issue 1, 2010, Pages 84-87

  Ji, Qing ^a,b   Karnak, David ^b   Hao, Ping ^a   Wang, Rongquan ^a   Xu, Liang ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cancer; MicroRNAs; Oncogene; Regulators; Stem cells

Indexed keywords

MICRORNA;

ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL RENEWAL; CELL SURVIVAL; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; MOLECULAR MECHANICS; MOLECULAR THERAPY; ONCOGENE; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

EID: 77955478701     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Al-Hajj M and Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004; 23: 7274-7282.
2. Wicha MS. Breast cancer stem cells: the other side of the story. Stem Cell Rev 2007; 3: 110-112; discussion 113.
3. Farnie G and Clarke RB. Mammary stem cells and breast cancer--role of Notch signalling. Stem Cell Rev 2007; 3: 169-175.
4. Dontu G, Al-Hajj M, Abdallah WM, Clarke MF and Wicha MS. Stem cells in normal breast development and breast cancer. Cell Prolif 2003; 36 Suppl 1: 59-72.
5. Yi SY and Nan KJ. Tumor-initiating stem cells in liver cancer. Cancer Biol Ther 2008; 7: 325-330.
6. Peacock CD and Watkins DN. Cancer stem cells and the ontogeny of lung cancer. J Clin Oncol 2008; 26: 2883-2889.
7. Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R and Jeter C. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol Carcinog 2007; 46: 1-14.
8. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles LE. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007; 104: 973-978.
9. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-1037.
10. Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951.
11. Clarke MF. A self-renewal assay for cancer stem cells. Cancer Chemother Pharmacol 2005; 56 Suppl 1: 64-68.
12. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988.
13. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM and Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593-598.
14. Rich JN. Cancer stem cells in radiation resistance. Cancer Res 2007; 67: 8980-8984.
15. Al-Hajj M. Cancer stem cells and oncology therapeutics. Curr Opin Oncol 2007; 19: 61-64.
16. Wicha MS. Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res 2006; 12: 5606-5607.
17. Hatfield S and Ruohola-Baker H. microRNA and stem cell function. Cell Tissue Res 2008; 331: 57-66.
18. Desano JT and Xu L. MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications. AAPS J 2009;
19. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W and Cui Q. An analysis of human microRNA and disease associations. PLoS One 2008; 3: e3420.
20. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R and Shah K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 2007; 67: 8994-9000.
21. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A and Lund AH. Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells. J Biol Chem 2008; 283: 1026-1033.
22. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S and Allgayer H. MicroRNA -21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-2136.
23. Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY. miR- 21-mediated tumor growth. Oncogene 2007; 26: 2799-2803.
24. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G and Hermeking H. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007; 6: 1586-1593.
25. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007; 6: 60.
26. Domen J, Gandy KL and Weissman IL. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 1998; 91: 2272-2282.
27. Domen J, Cheshier SH and Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med 2000; 191: 253-264.
28. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D and Xu L. Restoration of tumor suppressor miR- 34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer 2008; 8: 266.
29. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, Fearon ER, Lawrence TS and Xu L. MicroRNA miR-34 inhibits human pancreatic cancer tumorinitiating cells. PLoS One 2009; 4: e6816.
30. Croce CM and Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122: 6-7.
31. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
32. Papagiannakopoulos T and Kosik KS. MicroRNAs: regulators of oncogenesis and stemness. BMC Med 2008; 6: 15.
33. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J and Song E. let -7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007; 131: 1109-1123.
34. Lowery AJ, Miller N, McNeill RE and Kerin MJ. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res 2008; 14: 360-365.
35. Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer 2007; 43: 1529-1544.
36. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A and Hodgson JG. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6: 14.